Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation alpha-emitting ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
A disease that often develops without symptoms could still be sending subtle warning signals—if you know what to look for.
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced preclinical results for ATNM-400 across ...
Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis—the detection ...
Former President Joe Biden is battling “aggressive” prostate cancer after doctors found a “small nodule” on his prostate during a routine medical exam. Prostate cancer is one of the most common ...
The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little spillover into surrounding tissue, explained Kenneth Rosenzweig, MD, a ...
Older men with prostate cancer who receive federal housing assistance at the time they are first diagnosed have better ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
The stigma around getting tested for prostate cancer is not great. Many men avoid getting tested for this reason, which is ...
In prostate cancer, hormone therapy is treatment to keep the cancer cells from getting testosterone, the main male hormone (androgen). Hormone therapy for prostate cancer is also called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results